Lataa...
A randomized, comparative, open-label study of efficacy and tolerability of alfuzosin, tamsulosin and silodosin in benign prostatic hyperplasia
OBJECTIVES: Benign prostatic hyperplasia (BPH) is a common and progressive disease affecting elderly males, often associated with lower urinary tract symptoms (LUTS). α1-blockers are the mainstay in symptomatic therapy of BPH. Because of their greater uroselectivity and minimal hemodynamic effects,...
Tallennettuna:
| Julkaisussa: | Indian J Pharmacol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medknow Publications & Media Pvt Ltd
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4825428/ https://ncbi.nlm.nih.gov/pubmed/27127315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.178825 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|